Creative Planning’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Creative Planning’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-264	Closed	-$35K	–	2514
2020 Q3	$35K	Buy	264 +40	+18%	+$6.69K	﹤0.01%	1938
2020 Q2	$38K	Hold	224	–	–	﹤0.01%	1784
2020 Q1	$32K	Hold	224	–	–	﹤0.01%	1683
2019 Q4	$74K	Hold	224	–	–	﹤0.01%	1786
2019 Q3	$112K	Buy	+224	New	+$126K	﹤0.01%	1701

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Creative Planning's NBRV Position: Q4 2020 in Review

Creative Planning sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 264 shares — an estimated $35K sold.

Creative Planning first reported a position in NBRV in Q3 2019 and held it in 5 quarters. The position peaked at $112K in Q3 2019. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

Creative Planning reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
Creative Planning sold 264 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $35K.
Creative Planning first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2019 and held it in 5 quarters.
Creative Planning's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $112K in Q3 2019.
33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on Creative Planning's 13F filing for Q4 2020, filed 29 Jan 2021.